Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 71Colorectal Neoplasms 34Rectal Neoplasms 33Esophageal Neoplasms 25Carcinoma, Non-Small-Cell Lung 24Esophageal Squamous Cell Carcinoma 23Pancreatic Neoplasms 16Stomach Neoplasms 15Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Adenocarcinoma Of Esophagus 14Sarcoma 11Ovarian Neoplasms 11Lung Neoplasms 11Colonic Neoplasms 11Carcinoma, Hepatocellular 11Prostatic Neoplasms 10Head and Neck Neoplasms 10Neoplasm Metastasis 9Urinary Bladder Neoplasms 8Uterine Cervical Neoplasms 7Recurrence 6Osteosarcoma 6Multiple Myeloma 5Fallopian Tube Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Breast Carcinoma In Situ 5Peritoneal Neoplasms 4Nasopharyngeal Carcinoma 4Locally Advanced Rectal Cancer 4

Interventions

Gemcitabine 11Cisplatin 11Nivolumab 4Doxorubicin 4pembrolizumab 3avelumab 3Radiotherapy 3Fluorouracil 3Docetaxel 3Carboplatin 3vinflunine 2pegfilgrastim 2Sunitinib 2Platinum 2Paclitaxel 2Immunoglobulin G 2Ifosfamide 2Disulfides 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1tremelimumab 1tocilizumab 1temsirolimus 1tamibarotene 1relatlimab 1merphos 1guadecitabine 1enzalutamide 1durvalumab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Urethral Neoplasms × Neoadjuvant Therapy × Clear all
NCT00080795 2012-10-22

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

M.D. Anderson Cancer Center

Phase 2 Completed
65 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡